Exchange: NASDAQ·Updated 04:01 AM EDT
ADAG logo

ADAG Adagene Inc - ADR

$3.60
$0.04
(1.10%)
Pre-Market
Prev Close $3.64
Mkt Cap$244.4M
Vol8.00

About ADAG

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
44

Bearish Sentiment

How do you feel about ADAG?

Advertisement|Remove ads.